Tokyo Tape
Sign in
← Terumo

Annual report

4543.TEDINET S100OS1S
Period2021-04-01 → 2022-03-31
Filed2022-07-26
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed

Amends S100OAR8. Amended by S100OSC2 (2022-07-26).

Key figures · 169
MetricValuePeriodScopeSource row
Revenue¥703.3bn2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥613.8bn2020-04-01 → 2021-03-31Cons.Revenue IFRS
Revenue¥628.9bn2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥599.5bn2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥587.8bn2017-04-01 → 2018-03-31dCons.Net sales (5-year summary)
Operating income¥116.0bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Operating income¥98.4bn2020-04-01 → 2021-03-31Cons.Operating profit loss IFRS
Ordinary income¥88.5bn2017-04-01 → 2018-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥114.5bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥97.1bn2020-04-01 → 2021-03-31Cons.Profit loss before tax IFRS
Profit before tax¥106.5bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥102.7bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥106.6bn2017-04-01 → 2018-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥88.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥77.3bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥85.2bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥79.5bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥75.6bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥91.3bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥88.8bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥77.2bn2020-04-01 → 2021-03-31Cons.Profit loss IFRS
Total assets¥1.47Tat 2022-03-31Cons.Assets IFRS
Total assets¥1.35Tat 2021-03-31Cons.Assets IFRS
Total assets¥1.24Tat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥1.12Tat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥1.06Tat 2018-03-31dCons.Total assets (5-year summary)
Total assets¥1.08Tat 2018-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥461.4bnat 2022-03-31Cons.Liabilities IFRS
Total liabilities¥494.5bnat 2021-03-31Cons.Liabilities IFRS
Net assets / equity¥1.01Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥856.7bnat 2021-03-31Cons.Equity IFRS
Net assets / equity¥754.9bnat 2020-03-31dCons.Equity IFRS
Net assets / equity¥535.9bnat 2018-03-31dCons.Net assets (5-year summary)
Equity (owners)¥1.01Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥856.7bnat 2021-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥754.8bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥698.0bnat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥550.3bnat 2018-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥205.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥200.8bnat 2021-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥166.9bnat 2020-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥123.0bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥167.8bnat 2018-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥141.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥121.5bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥117.5bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥93.6bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥112.4bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥114.6bn2017-04-01 → 2018-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥78.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥85.3bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥84.7bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥74.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥42.2bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥44.1bn2017-04-01 → 2018-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥70.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥7.4bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥14.0bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥67.5bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥3.9bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.1bn2017-04-01 → 2018-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥117.452021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥102.332020-04-01 → 2021-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥113.962019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥108.72018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥107.282017-04-01 → 2018-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥129.562017-04-01 → 2018-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥117.382021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥102.112020-04-01 → 2021-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥112.612019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥104.972018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥99.912017-04-01 → 2018-03-31dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥121.032017-04-01 → 2018-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,338.46at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,133.13at 2021-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,003.36at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥939.6at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥756.49at 2018-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥777.94at 2018-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio68.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio63.4%at 2021-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio60.8%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.3%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.6%at 2018-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio50.9%at 2018-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE9.5%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE9.6%2020-04-01 → 2021-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE11.7%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE12.7%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE14.8%2017-04-01 → 2018-03-31dCons.Rate of return on equity (5-year summary)
ROE17.5%2017-04-01 → 2018-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees28,294at 2022-03-31Cons.Number of employees
Employees26,482at 2021-03-31Cons.Number of employees
Employees26,438at 2020-03-31dCons.Number of employees
Employees25,378at 2019-03-31dCons.Number of employees
Employees23,319at 2018-03-31dCons.Number of employees
Revenue¥341.4bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥316.4bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥319.0bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥307.0bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥292.9bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥59.4bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥51.9bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥79.4bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥65.3bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥80.1bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥72.9bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥85.4bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥78.8bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥65.8bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥62.8bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥52.0bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥65.3bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥58.1bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥64.5bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.28Tat 2022-03-31StandaloneAssets
Total assets¥1.26Tat 2021-03-31StandaloneAssets
Total assets¥1.15Tat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.04Tat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.03Tat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥517.3bnat 2022-03-31StandaloneLiabilities
Total liabilities¥537.5bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥765.4bnat 2022-03-31StandaloneNet assets
Net assets / equity¥725.2bnat 2021-03-31StandaloneNet assets
Net assets / equity¥687.2bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥624.9bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥516.8bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥98.3bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥107.4bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥83.042021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥68.892020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥87.312019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥79.472018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥91.512017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥82.992021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥68.742020-04-01 → 2021-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥86.292019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥76.782018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥85.222017-04-01 → 2018-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥342021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥292020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥282019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥542018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥502017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,011.08at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥958.26at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥912.44at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥840.16at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥729.63at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio59.6%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio57.4%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio59.7%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio59.9%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio50.2%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE8.4%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE7.4%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE10.0%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE10.2%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE13.2%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued759,521,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued759,521,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued759,521,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued379,760,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued379,760,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees5,377at 2022-03-31StandaloneNumber of employees
Employees5,247at 2021-03-31StandaloneNumber of employees
Employees5,087at 2020-03-31dStandaloneNumber of employees
Employees4,908at 2019-03-31dStandaloneNumber of employees
Employees4,781at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2021-04-01 → 2022-03-31¥4.4bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2022-03-31¥251m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥3.2bn
Blood And Cell Technologies Companyreportable segmentcapex2021-04-01 → 2022-03-31¥17.6bn
Blood And Cell Technologies Companyreportable segmentemployeesat 2022-03-316366 pure
Blood And Cell Technologies Companyreportable segmentrevenue external2021-04-01 → 2022-03-31¥120.6bn
Blood And Cell Technologies Companyreportable segmentsegment profit2021-04-01 → 2022-03-31¥20.8bn
Cardiac And Vascular Companyreportable segmentcapex2021-04-01 → 2022-03-31¥32.0bn
Cardiac And Vascular Companyreportable segmentemployeesat 2022-03-3114780 pure
Cardiac And Vascular Companyreportable segmentrevenue external2021-04-01 → 2022-03-31¥397.1bn
Cardiac And Vascular Companyreportable segmentsegment profit2021-04-01 → 2022-03-31¥93.2bn
Medical Care Solutions Companyreportable segmentcapex2021-04-01 → 2022-03-31¥15.3bn
Medical Care Solutions Companyreportable segmentemployeesat 2022-03-316115 pure
Medical Care Solutions Companyreportable segmentrevenue external2021-04-01 → 2022-03-31¥185.3bn
Medical Care Solutions Companyreportable segmentsegment profit2021-04-01 → 2022-03-31¥23.6bn
—segment totalcapex2021-04-01 → 2022-03-31¥64.8bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥703.1bn
—segment totalsegment profit2021-04-01 → 2022-03-31¥137.7bn
Reconciling Itemsreconcilingcapex2020-04-01 → 2021-03-31¥4.2bn
Reconciling Itemsreconcilingrevenue external2020-04-01 → 2021-03-31¥256m
Reconciling Itemsreconcilingsegment profit2020-04-01 → 2021-03-31−¥3.3bn
Blood And Cell Technologies Companyreportable segmentcapex2020-04-01 → 2021-03-31¥23.3bn
Blood And Cell Technologies Companyreportable segmentrevenue external2020-04-01 → 2021-03-31¥109.5bn
Blood And Cell Technologies Companyreportable segmentsegment profit2020-04-01 → 2021-03-31¥19.1bn
Cardiac And Vascular Companyreportable segmentcapex2020-04-01 → 2021-03-31¥34.6bn
Cardiac And Vascular Companyreportable segmentrevenue external2020-04-01 → 2021-03-31¥328.5bn
Cardiac And Vascular Companyreportable segmentsegment profit2020-04-01 → 2021-03-31¥74.4bn
Medical Care Solutions Companyreportable segmentcapex2020-04-01 → 2021-03-31¥15.1bn
Medical Care Solutions Companyreportable segmentrevenue external2020-04-01 → 2021-03-31¥175.5bn
Medical Care Solutions Companyreportable segmentsegment profit2020-04-01 → 2021-03-31¥25.7bn
—segment totalcapex2020-04-01 → 2021-03-31¥73.0bn
—segment totalrevenue external2020-04-01 → 2021-03-31¥613.6bn
—segment totalsegment profit2020-04-01 → 2021-03-31¥119.2bn
Blood And Cell Technologies Companyreportable segmentemployeesat 2022-03-31260 pure
Cardiac And Vascular Companyreportable segmentemployeesat 2022-03-311791 pure
Medical Care Solutions Companyreportable segmentemployeesat 2022-03-312364 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,799
ItemContextValueUnit
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember192000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-3000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember188000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember608000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember40054000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember192000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember192000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-3000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember40243000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-6229000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember762127000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember2577000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember2577000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember707000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember765412000000JPY
Freightage and packing expenses sgaPrior1YearDuration_NonConsolidatedMember9092000000JPY
Freightage and packing expenses sgaCurrentYearDuration_NonConsolidatedMember8979000000JPY
Salaries sgaPrior1YearDuration_NonConsolidatedMember10791000000JPY
Salaries sgaCurrentYearDuration_NonConsolidatedMember11079000000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember2645000000JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember2499000000JPY
Provision for directors bonuses sgaPrior1YearDuration_NonConsolidatedMember94000000JPY
Provision for directors bonuses sgaCurrentYearDuration_NonConsolidatedMember132000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember22934000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember24081000000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember3221000000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember3540000000JPY
Provision of allowance for doubtful accounts sgaPrior1YearDuration_NonConsolidatedMember65000000JPY
Provision of allowance for doubtful accounts sgaCurrentYearDuration_NonConsolidatedMember-26000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書（2022年７月26日付け訂正報告書の添付インラインXBRL）
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-06-23
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第107期(自　2021年４月１日　至　2022年３月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)テルモ株式会社
Company name in english cover pageFilingDateInstantTERUMO CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長CEO　佐藤　慎次郎
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都渋谷区幡ケ谷二丁目44番１号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(3374)8111(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstantText · Plus
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都新宿区西新宿三丁目20番２号 東京オペラシティタワー 49F
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(6742)8500(代表)
Name of contact person nearest place of contact cover pageFilingDateInstantText · Plus
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE01630
Fund codeFilingDateInstant－
Security codeFilingDateInstant45430
Filer name in japaneseFilingDateInstant
Original text (Japanese)テルモ株式会社
Filer name in englishFilingDateInstantTERUMO CORPORATION
Fund name in japaneseFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass